GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Darlath, Wilfried  (2)
Material
Publisher
Person/Organisation
Language
Years
FID
  • 1
    In: Pharmacology, S. Karger AG, Vol. 76, No. 1 ( 2006), p. 40-45
    Abstract: The relief of nasal congestion with the antihistamine fexofenadine in seasonal allergic rhinitis is thought to be due to its additional anti-inflammatory properties. The objective of this study was to evaluate the in vitro effects of fexofenadine on stimulated arachidonic acid metabolism. Human monocytes, isolated from blood and donated by 5 healthy volunteers, were either incubated for 20 h with 10 µg/ml lipopolysaccharide, with and without fexofenadine (10 〈 sup 〉 –8 〈 /sup 〉 –10 〈 sup 〉 –3 〈 /sup 〉 mol/l, n = 8–19), or were incubated for 20 h, with and without fexofenadine, and then stimulated with 0.5 mg/ml zymosan for 2 h. Leukotriene B 〈 sub 〉 4 〈 /sub 〉 (LTB 〈 sub 〉 4 〈 /sub 〉 ), LTC 〈 sub 〉 4 〈 /sub 〉 , LTD 〈 sub 〉 4 〈 /sub 〉 and LTE 〈 sub 〉 4 〈 /sub 〉 , prostaglandin E 〈 sub 〉 2 〈 /sub 〉 (PGE 〈 sub 〉 2 〈 /sub 〉 ) and F 〈 sub 〉 2 〈 /sub 〉 α(PGF 〈 sub 〉 2 〈 /sub 〉 α) production was determined by enzyme immunoassay. Zymosan-stimulated production of LTC 〈 sub 〉 4 〈 /sub 〉 , LTD 〈 sub 〉 4 〈 /sub 〉 and LTE 〈 sub 〉 4 〈 /sub 〉 was significantly inhibited by clinically relevant concentrations of fexofenadine HCl: 10 〈 sup 〉 –7 〈 /sup 〉 mol/l (22% inhibition vs. control, p = 0.008) and 10 〈 sup 〉 –6 〈 /sup 〉 mol/l (24% inhibition vs. control, p = 0.020). Higher concentrations of fexofenadine (10 〈 sup 〉 –4 〈 /sup 〉 and 10 〈 sup 〉 –3 〈 /sup 〉 mol/l) inhibited LTB 〈 sub 〉 4 〈 /sub 〉 generation. Lipopolysaccharide-stimulated production of PGE 〈 sub 〉 2 〈 /sub 〉 was significantly inhibited by fexofenadine HCI 10 〈 sup 〉 –6 〈 /sup 〉 mol/l (26% inhibition, p = 0.035) and 10 〈 sup 〉 –5 〈 /sup 〉 mol/l (40% inhibition, p = 0.001). Higher concentrations of fexofenadine HCI (10 〈 sup 〉 –4 〈 /sup 〉 and 10 〈 sup 〉 –3 〈 /sup 〉 mol/l) significantly inhibited PGF 〈 sub 〉 2 〈 /sub 〉 α production by 50% (p = 0.026) and 63% (p = 0.001), respectively. Fexofenadine, at both clinically relevant and higher concentrations, inhibits LTC 〈 sub 〉 4 〈 /sub 〉 , LTD 〈 sub 〉 4 〈 /sub 〉 , LTE 〈 sub 〉 4 〈 /sub 〉 and PGE 〈 sub 〉 2 〈 /sub 〉 in cultured human monocytes. These additional anti-inflammatory properties may underlie the relief of nasal congestion observed in clinical studies.
    Type of Medium: Online Resource
    ISSN: 0031-7012 , 1423-0313
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2006
    detail.hit.zdb_id: 1483550-2
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Pharmacology, S. Karger AG, Vol. 78, No. 3 ( 2006), p. 129-135
    Abstract: 〈 i 〉 Background/Aims: 〈 /i 〉 Fexofenadine HCl (FEX) has previously been shown to have anti-inflammatory properties in relieving nasal congestion in allergic rhinitis. The objective of this study was to further elucidate the mechanism of action behind the anti-inflammatory properties of FEX in addition to its H 〈 sub 〉 1 〈 /sub 〉 -receptor antagonism. 〈 i 〉 Methods: 〈 /i 〉 The effects of two antihistamines, FEX and loratadine (LOR), were investigated on cyclooxygenase (COX)-1 and -2 enzymesin vitro. FEX (10 〈 sup 〉 –9 〈 /sup 〉 –10 〈 sup 〉 –3 〈 /sup 〉 mol/l) and LOR (10 〈 sup 〉 –9 〈 /sup 〉 –10 〈 sup 〉 –4 〈 /sup 〉 mol/l) were incubated with arachidonic acid in a COX screening assay with either ovine COX-1 or COX-2 or human COX-2. COX-2 enzyme inhibitory activity for the antihistamines was compared with the known selective COX-2 inhibitor DuP-679. 〈 i 〉 Results: 〈 /i 〉 High concentrations of FEX (10 〈 sup 〉 –3 〈 /sup 〉 mol/l) significantly inhibited arachidonic acid-mediated ovine COX-1 activity, but low concentrations had no effect. Low concentrations of FEX (10 〈 sup 〉 –8 〈 /sup 〉 mol/l) inhibited ovine COX-2 activity, and this inhibition decreased with increasing concentrations. The inhibition of COX-2 activity by FEX was similar to that seen with the selective COX-2 inhibitor, DuP-679. Conversely, LOR inhibited COX-1 activity at low concentrations (10 〈 sup 〉 –8 〈 /sup 〉 mol/l), but had little inhibitory effect on COX-1 at high concentrations. LOR (10 〈 sup 〉 –5 〈 /sup 〉 mol/l) markedly stimulated COX-2 activity. 〈 i 〉 Conclusion: 〈 /i 〉 FEX showed selective arachidonic acid-mediated COX-2 inhibitory enzyme activity, which differed markedly from the COX inhibitory enzyme activity of LOR. This selective COX-2 inhibitor activity by FEX may contribute to its anti-inflammatory properties in relieving nasal congestion in allergic rhinitis.
    Type of Medium: Online Resource
    ISSN: 0031-7012 , 1423-0313
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2006
    detail.hit.zdb_id: 1483550-2
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...